Mitoquinone mesylate as post-exposure prophylaxis against SARS-CoV-2 infection in humans: an exploratory single center pragmatic open label non-randomized pilot clinical trial with matched controls
Related Posts
Srinagesh HK, Gupta VK, Zhang A, Grunwald MR, Connor MP, Kota VK, Boccucci J, Ulrickson ML, Pradeep R, Hill LC, Tsai SB, O'Connor TE, Sandhu[...]
Appley M, Gray JR, Abdulrahim D, Bowden-Jones O. Grayken lessons: a multidisciplinary approach to care for a patient with severe ketamine use disorder. Addict Sci[...]
Tai JW, Shah VD, Harmon RL, Chandna S, Yan J, Fathizadeh P, Beaven S, Karunasiri D, Kim P. Vanishing Bile Duct Syndrome as a Rare[...]